NCT06186375View on ClinicalTrials.gov

Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

Active, not recruitingOBSERVATIONAL
Enrollment

239

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

March 31, 2026

Conditions
Polyarthritis; Rheumatoid
Interventions
OTHER

Patients with planned biotherapy

Single additional volume of blood (10 ml) to be collected using the PAXgene system at the same time as the routine blood test before starting biotherapy.

Trial Locations (4)

21000

University Hospital of DIJON, Dijon

42270

University Hospital of Saint-Etienne, Saint-Priest-en-Jarez

45100

Hospital of Orleans, Orléans

59037

Hôpital Roger Salengro University Hospital of Lille, Lille

Sponsors

Lead Sponsor

CEN Biotech
All Listed Sponsors
collaborator

MYEXPRESION

UNKNOWN

lead

CEN Biotech

INDUSTRY

NCT06186375 - Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter